Pharmaceutical stocks largely shook off the brunt of negotiated drug prices. But that doesn't mean they'll be spared election noise.

Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape ...

The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032.

Prior to Viela, Mr. Chan held various financial and investor relations leadership roles at AstraZeneca and Genentech-Roche, among other companies. He has served on the Board of Directors of Avalo ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

AstraZeneca's Imfinzi was used before and after surgery in a clinical trial of patients with muscle-invasive bladder cancer — ...

Dr. Beck’s extensive experience in CMC and product development will be instrumental as Abata enters clinical development this ...

For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place ...

The US Food and Drug Administration (FDA) has approved Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs), the first and ...

Innosphere Ventures has added a new face to its board of directors. Liz Scott is vice president of sales at Applied ...

Biotechnology is at the forefront of innovation, transforming healthcare and pushing the boundaries of what’s possible. As groundbreaking discoveries unfold daily—from cutting-edge therapies to ...